The White Cap Research Group

New Recommendation

Marc Lichtenfeld — Tue, 09 Mar 2010 15:01:18 +0000

Today, I am recommending Sangamo BioSciences (Nasdaq: SGMO). The company’s zinc finger technology can turn any gene in any cell in any organism on or off. Its business model is diverse. While it develops novel therapeutics, it also licenses its technology to Fortune 1000 companies. Read the report here. We will have a conference call with management [...]

A Leaps Lesson

Karim Rahemtulla — Mon, 08 Mar 2010 20:23:11 +0000

Email – #507 Congratulations on the win on the USAir trade! Officially we were out with a 67% gain on the original position and positioned ourselves to make a quadruple digit gain on our spread trade with NO RISK. We were able to sell the $10 January option at exactly the same price or more than we [...]

The White Cap Report – Smash Hit or Trash It!

White Cap Research Team — Fri, 05 Mar 2010 20:23:35 +0000

Without further ado, it’s time for another round of Smash Hit or Trash Hit!. You know the drill… The “Smash Hit” companies are ones we feel have an above-average potential for capital appreciation in the weeks and months ahead. The “Trash It” companies are headed nowhere fast. And don’t forget, these are not [...]

White Cap Flight Deck – Mission #9

Karim Rahemtulla — Fri, 05 Mar 2010 20:21:29 +0000

White Cap Flight Deck – Mission #9 Dear White Cap Nation, I often get asked why I use long-dated options instead of the myriad of ultra-long and ultra-short ETFs. Such ETFs promise two or three times the returns from the underlying investment. Given that, many think, “Why not buy the ultra-long ETF. If [...]

Instant Money Trader #167

Lee Lowell — Fri, 05 Mar 2010 19:19:09 +0000

Hello Instant Money Traders Now that we’ve closed out two trades profitably this week, we’re watching our other three open positions for the best time to close those out as well. Our Home Depot put-sell trade is next in line for a profitable finish and I most likely will have us close it out [...]

CLDX Reports 4th Quarter Results

Marc Lichtenfeld — Fri, 05 Mar 2010 16:19:00 +0000

Celldex Therapeutics (Nasdaq: CLDX) reported fourth quarter results this morning. The company lost 43 cents per share on revenue of $4.7 million. As you’re aware, we’re more concerned with cash on hand and clinical developments than with earnings in these early stage companies. CLDX has $82 million and expects to have enough cash to take it [...]

TZP Update: #367

Lee Lowell — Fri, 05 Mar 2010 15:13:42 +0000

Hello TZP members. Crude Oil The crude oil market continues to move higher in our favor, so I want to place an order to buy back our bullish put option credit spread. Here’s what you need to do: Buy back your June 2010 crude oil $68.50/$69.00 put option credit spread for a limit spread [...]

Instant Money Trader #164

Lee Lowell — Wed, 03 Mar 2010 15:09:01 +0000

Hello Instant Money Traders. Du Pont (DD) We currently have a position in which we sold the Du Pont April 2010 $27.00 put options for a sale price of $.30 per contract. We’re going to place an order to buy these options back and lock in our gains. Here’s what you need to do: Buy back [...]

SCLN Reports Strong Quarter and Raises Guidance

Marc Lichtenfeld — Wed, 03 Mar 2010 14:38:12 +0000

Last night, SciClone Pharmaceuticals (Nasdaq: SCLN) delivered the news we hoped it would. The company reported 4th quarter earnings of 5 cents per share on revenue of $18.1 million. Sales were in line with the consensus estimate but EPS came in ahead of the consensus of 2 cents. Zadaxin sales in China jumped [...]

Your March Report Is Now Available

Matthew Weinschenk — Tue, 02 Mar 2010 19:05:45 +0000

I’ve just put the finishing touches on this month’s full report of The FastCap Strategist. Click here to access the March 2010 Report Your username and password appear below. You’ll need it to view the issue. Last week, I said we’d have two new recommendations in this issue. However, Open Text Corporation (Nasdaq: OTEX) [...]